Company Overview of Pfizer Ltd.
Pfizer Ltd. is a biopharmaceutical company that discovers, develops, and provides medicines, vaccines, and consumer healthcare products for people in the United Kingdom and internationally. It offers prescription medicines, non-prescription medicines, over-the-counter products, counterfeit medicines, and vitamins and mineral supplements. The company offers products for various illnesses and diseases, such as cardiovascular disease, pain and arthritis, headaches, joint and back pain, cough, dry and itchy skin, certain types of cancers, and rare diseases that afflict only small numbers of people. The company was founded in 1952 and is based in Walton on the Hill, United Kingdom. Pfizer Ltd. op...
Walton on the Hill, KT20 7NS
Founded in 1952
Key Executives for Pfizer Ltd.
Managing Director and Head of Global Innovative Pharmaceutical Business Uk
President of Worldwide Research and Development
Head of Business Development of Health Solutions UK
Commercial Account Director
Compensation as of Fiscal Year 2016.
Pfizer Ltd. Key Developments
Pfizer Wins GBP 696.9 Million Multiple Awardees Contract for Pharmaceutical Products
Aug 20 16
Pfizer Ltd. won a GBP 696.9 million multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the
Department of Health) for pharmaceutical products (Tranche A including Hepatitis C) (Contract Award Notice No.: 2016/S 158-286599).
Pfizer Ltd. Wins GBP 562,276 Multiple Awardees Contract for Supplying Vorinconazole Tablets, Intravenous Infusion and Oral Suspension
Jul 16 16
Pfizer Ltd. has won GBP 562,276 (excluding VAT) multiple awardees contract award from The Common Services Agency for the supply of Vorinconazole tablets, intravenous infusion and oral suspension.
Pfizer Ltd. Wins Multiple Awardees Contract Award from the Secretary of State
Jun 8 16
Pfizer Ltd. won a multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit for the supply of recombinant Factor IX products.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries